Polymyxin B-Induced Skin Hyperpigmentation

Xueke Wen1, Chunliu Luo2, Weitao Lyu2

  • 1The First Clinical Medical College of Jinan University, No. 601 Huangpu Avenue West, Guangzhou City 510630, Guangdong Province, China.

Case Reports in Medicine
|October 5, 2020
PubMed

Insights

Polymyxin B can cause rare skin hyperpigmentation and desquamation as an adverse drug reaction. Symptoms resolved within sixty days after discontinuing the antibiotic treatment.

Area of Science:

  • Dermatology
  • Infectious Diseases
  • Pharmacology

Background:

  • Polymyxin B is an antibiotic used for multidrug-resistant Gram-negative infections.
  • Skin hyperpigmentation is a rare but documented adverse drug reaction (ADR) to Polymyxin B.
  • Multidrug-resistant infections pose a significant clinical challenge, necessitating effective treatment options.

Related Concept Videos

Pigmentation01:19

Pigmentation

The color of the skin is influenced by a number of pigments, including melanin, carotene, and hemoglobin. Recall that melanin is produced by cells called melanocytes, which are found scattered throughout the stratum basale of the epidermis. The melanin is transferred to the keratinocytes via melanosomes.
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
3.9K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.1K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
551